EGFR and hepatocellular carcinoma: Among these potential targets, MAPK1, PIK3CA, EGFR, CCND1, and NFKBIA were identified as relatively high-degree targets, which played an essential role in cell proliferation and survival and were considered as the key markers of ZJP treatment on HCC.